Claims
- 1. A method of treating inflammatory bowel disease in a mammal with that disease comprising administering to the mammal a pharmacologically effective amount of an inhibitor of both phosphodiesterase 2 and phosphodiesterase 5 with the proviso that said inhibitor has a cyclooxygenase inhibition of less than about 25% at 100 μM.
- 2. A method of treating inflammatory bowel disease in a mammal with that disease comprising administering to the mammal a pharmacologically effective amount of an inhibitor of both phosphodiesterase 2 and phosphodiesterase 5 with the proviso that said inhibitor has a cyclooxygenase inhibition of less than about 25% at 100 μM and an IC50 of no more than about 14 μM for said phosphodiesterases.
Parent Case Info
This application is a continuation under 35 U.S.C. §120 to U.S. patent application Ser. No. 09/789,848, filed Feb. 21, 2001, now abandoned.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
6066634 |
Sperl et al. |
May 2000 |
A |
Continuations (1)
|
Number |
Date |
Country |
Parent |
09/789848 |
Feb 2001 |
US |
Child |
10/252286 |
|
US |